Determination of Key Intermediates in Cholesterol and Bile Acid Biosynthesis by Stable Isotope Dilution Mass Spectrometry
Tadashi Yoshida1, Akira Honda2, Hiroshi Miyazaki3 and Yasushi Matsuzaki2
1Raffles Japanese Clinic, Singapore, Singapore. 2Tokyo Medical University, Kasumigaura Hospital, Ibaraki, Japan. 3Pharmax Institute, Kanagawa, Japan.
Abstract
For more than a decade, we have developed stable isotope dilution mass spectrometry methods to quantify key intermediates in cholesterol and bile acid biosynthesis, mevalonate and oxysterols, respectively. The methods are more sensitive and reproducible than conventional radioisotope (RI), gas-chromatography (GC) or high-performance liquid chromatography (HPLC) methods, so that they are applicable not only to samples from experimental animals but also to small amounts of human specimens. In this paper, we review the development of stable isotope dilution mass spectrometry for quantifying mevalonate and oxysterols in biological materials, and demonstrate the usefulness of this technique.
Readers of this also read:
- High-Performance Liquid Chromatographic Method for Determination of Phenytoin in Rabbits Receiving Sildenafil
- Detecting the Site of Phosphorylation in Phosphopeptides Without Loss of Phosphate Group Using MALDI TOF Mass Spectrometry
- Optimized and Validated Spectrophotometric Methods for the Determination of Enalapril Maleate in Commercial Dosage Forms
- Understanding Structural Features of Microbial Lipases - An Overview
- Solid-Phase Extraction and Reverse-Phase HPLC: Application to Study the Urinary Excretion Pattern of Benzophenone-3 and its Metabolite 2,4-Dihydroxybenzophenone in Human Urine